ArticleThe Journal of thoracic and cardiovascular surgery2014

Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.

Pavan Atluri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.